Clinical Trials Logo

Clinical Trial Summary

Magnesium sulfate has many mechanisms of action for attenuating the stress response as inhibition of catecholamine releasing from the adrenal medulla, keeping the plasma concentration of epinephrine at a fixed level, decreasing the circulating norepinephrine level when compared to that of a control group[ and also has a vasodilation effect on systemic and coronary blood vessels by blocking calcium ion in vascular smooth muscle.-Methyl- D-Aspartate (NMDA) antagonism is an amazing recent discovery for magnesium sulphate to play an important role in stress response. In this study, we will study the effects of nebulized magnesium sulfate on hemodynamics during intubation.


Clinical Trial Description

Inclusion criteria - 20-50 years old - ASA: 1, 2 - Elective fit laparoscopic cholecystectomy Exclusion criteria - Patient refusal - patients with history of hypersensitivity to magnesium sulphate - patients with coronary ischemic disease, atrioventricular block of any degree, known cardiac arrhythmias, heart failure - on beta blockers or calcium channel blockers - expected difficult intubation (Mallampati 4) - Body mass index > 40 Study tools: Following institutional ethical committee approval and written informed consent,a prospective randomized double-blinded study. After written informed consent wil be given, 100 patients, ASA 1 or 2, aged between 20 - 50 years, scheduled for elective surgery with Orotracheal Intubation (OTI) will be assessed for eligibility. Patients will be recruited in the study divided into two equal groups; Patients in Group A: will receive nebulized magnesium sulfate in 3 ml (240 mg) over 15 min, While group B: will receive nebulized normal saline in 3 ml over 15 min, ending 5 min before the induction of anesthesia. SBP, DBP, HR, and blood glucose level will be measured at the following intervals; Baseline (before induction), after premedication (sedation), after induction, after ETT intubation, 3 min later, 6 min later. Full monitoring data (Blood pressure every 3 minutes, ECG, Nanogram, and pulse oximeter) wil be collected till 6 minutes then every 5 minutes. Random blood sugar will be tested 5 minutes pre-intubation, 3minutes and 5 minutes after intubation. After end of nebulization, sedation with 2 mg midazolam and IV fluids (10 ml/kg) will be infused to avoid tachycardia of dehydration and fear of surgery. Then, we proceed on general anesthesia through propool titration + fentanyl 100 mcg + Cisatracurium 0.15 mg/kg. Endotracheal intubation with cuffed tube and mechanical ventilation with mild increase in respiratory rate 14-16/min to overcome CO2 peritoneal insufflation. All patients will receive intraoperatively, nalbuphine 0.1 mg/kg + ketorolac 60 mg + paracetamol IV 1 g. Dexamethasone 4mg + Ondansetron 4mg will be received to all patients for prophylaxis against postoperative nausea and vomiting. After end of surgery, cessation of inhalational anesthesia and reversal of muscle relaxation with neostigmine 2.5 mg+ Atropine 1mg will be done. Consumption of isoflurane intraoperatively will be recorded. Post operative assessment for pain using VAS score will be assessed 2 hours after recovery. Time for recovery after stop of isoflurane will be estimated. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06091631
Study type Interventional
Source Assiut University
Contact
Status Not yet recruiting
Phase N/A
Start date November 2023
Completion date August 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03591432 - A Trial Comparing Transnasal humidified Rapid insufflation Ventilatory Exchange (THRIVE) and Apneic Oxygenation With Facemask Ventilation in Elderly Patients Undergoing Induction of Anaesthesia. N/A
Recruiting NCT01790646 - Learning and Performance of Glidescope® Videolaryngoscope Intubation N/A
Completed NCT01518608 - Alfentanil and the Elimination of Sympathetic Responses to Tracheal Intubation During Rapid Sequence Induction of Anesthesia: A Probability-based Approach Phase 4
Not yet recruiting NCT04268043 - Comparation of Proseal Laryngeal Mask Airway With Flexible Laryngeal Airway Mask N/A
Recruiting NCT03902704 - Safety and Efficacy of Cleverscope. A New Medical Device for Tracheal Intubation N/A
Completed NCT05383417 - No Post Intubation Laryngeal Symptoms N/A
Recruiting NCT04864106 - Comprehensive Preoperative Airway Grading N/A
Active, not recruiting NCT02627755 - GlideScope® vs GlideScope® + aScope® for Managing Difficult Airways. N/A
Completed NCT04085744 - A Comparison Of Local Anesthetic Agents And Steroid On Tracheal Tube Cuff N/A
Completed NCT04802122 - Induction of Anesthesia With Sevoflurane Preserving Spontaneous Breathing: Cardiorespiratory Effects. Phase 4
Completed NCT05366582 - Neural Integrity Monitor Electromyogram (NIM-EMG) Endotracheal Tube Intubation With Video Laryngoscope N/A
Completed NCT03631875 - Co-induction Ketamine-propofol: Effects on Laryngeal Mask Airway Insertion Conditions in Children Phase 4
Completed NCT04110899 - Paratracheal Force Required for Occluding the Upper Esophagus N/A
Not yet recruiting NCT05279170 - MAsk VEntilation With Paratracheal Pressure In Children. Para Tracheal Compression to Prevent Gastric Insufflation in Children N/A
Completed NCT01289769 - The Effect of Dexmedetomidine on Hemodynamic Response During Double Lumen Endotracheal Intubation Phase 2
Completed NCT03833947 - Dexamethasone vs Bicarbonate to Intracuff Lignocaine 2% in General Anaesthesia Phase 4
Completed NCT04779528 - Awake Nasal Fiber-optic Intubation of Severely Obese Patients in Lateral Position N/A
Recruiting NCT05433155 - Nasotracheal Intubation With VL vs DL in Infants Trial N/A
Completed NCT05432570 - Use of Muscle Relaxants in Parotidectomy Operation With Neuromonitoring N/A
Completed NCT02442128 - Fentanyl and Propofol for Tracheal Intubation During Sevoflurane Induction Without Muscle Relaxants in Children N/A